Jiangsu Skyray Instrument Co Ltd

Jiangsu Skyray Instrument Co Ltd has a market price of 6.9 CNY per share, resulting in a market capitalization of 3.42 billion CNY. The company's price-to-book ratio is 3.28, and its price-to-tangible-book ratio is also 3.28, indicating that the market is valuing the company's equity at a premium relative to its book value. The enterprise value to EBITDA ratio is negative at -20.12, reflecting the company's current operating losses. The enterprise value to revenue ratio is 7.46, suggesting that the company is trading at a multiple of its revenue. The company's profitability metrics are concerning. The return on equity is -22.33%, and the return on assets is -7.74%, both significantly below the industry median for industrial machinery and equipment firms. The operating income is negative at -229.56 million CNY, and the net income is also negative at -232.83 million CNY. The gross profit margin is 36.77%, which is relatively high but insufficient to offset the company's operating expenses. Jiangsu Skyray Instrument Co Ltd's revenue is concentrated in a single geographic region, primarily the People's Republic of China. The company does not disclose specific segment data, but its operations are focused on the production and sale of medical imaging equipment. The lack of geographic or product diversification increases the company's exposure to regional economic and regulatory risks. The company's growth trajectory is mixed. While the company has a positive operating cash flow of 203.63 million CNY, its free cash flow is negative at -275.17 million CNY. The capital expenditure for the period is -4.98 million CNY, indicating minimal investment in new assets. The company's revenue for the period is 619.14 million CNY, but the outlook for the current fiscal year is uncertain due to the company's operating losses and negative net income. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag is that the company has negative net cash after subtracting total debt, which could impact its ability to meet short-term obligations. The debt-to-equity ratio is 1.15, suggesting a moderate level of leverage. The current ratio is 3.16, indicating that the company has sufficient current assets to cover its current liabilities. Recent events and filings do not provide specific details on the company's strategic initiatives or operational changes. The company's financial performance and risk profile suggest that it may need to address its operating losses and improve its cash flow generation to sustain long-term growth. The company's reliance on a single geographic market and the absence of detailed segment data further complicate its strategic outlook.